Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Topical moxidectin effectively treats mange in wombats.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Provenge extends prostate cancer survival by about 4 months.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

ALRN-6924 may prevent hair loss caused by chemotherapy.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Intralesional cidofovir might be a good alternative treatment.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.